Skip to search boxSkip to navigationSkip to main content

Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America

  • Ignacio F. Mata(corresponding author)
    ,
  • Greggory J. Wilhoite
    ,
  • Dora Yearout
    ,
  • Justin A. Bacon
    ,
  • ,
  • Pilar Mazzetti
*Corresponding author for this work
  • VA Puget Sound Health Care System
    ,
  • University of Washington School of Medicine
    ,
  • Mayo Clinic in Jacksonville, Florida
    ,
  • docencia y atención especializada en epilepsia
    ,
  • Universidad Nacional Mayor de San Marcos
    ,
  • Universidad Nacional del Altiplano
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 629-631 (3 pages)

Journal (Volume, Issue Number)

Parkinsonism and Related Disorders (Volume 17, Issue 8)

Publication milestones

  • Published - 09/2011

Publication status

Published - 09/2011

ISSN

1353-8020

Publication IDs

  • Scopus: 80052366563
  • PubMed: 21632271

Abstract

Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease, with frequencies displaying a high degree of population-specificity. Although more than 100 coding substitutions have been identified, only seven have been proven to be highly penetrant pathogenic mutations. Studies however are lacking in non-white populations. Recently, Lrrk2 p.Q1111H (rs78365431) was identified in two affected Hispanic brothers and absent in 386 non-Hispanic white healthy controls. We therefore screened this variant in 1460 individuals (1150 PD patients and 310 healthy controls) from 4 Latin American countries (Peru, Chile, Uruguay and Argentina).In our case-control series from Peru and Chile we observed an increased frequency of Lrrk2 p.Q1111H in patients (7.9%) compared to controls (5.4%) although the difference did not reach significance (OR 1.38; p = 0.10).In addition, the frequency of Lrrk2 p.Q1111H varied greatly between populations and further screening in a set of pure Amerindian and pure Spanish controls suggested that this variant likely originated in an Amerindian population. Further studies in other Latin American populations are warranted to assess its role as a risk factor for Parkinson's disease. Screening in Parkinson's disease patients from under-represented populations will increase our understanding of the role of LRRK2 variants in disease risk worldwide.

Funding Details

This work was supported by the National Institutes of Health ( R01 NS065070 , P50 NS062684 , P50 NS072187 ), Department of Veterans Affairs ( 1I01BX000531 ), FONDECYT (# 1061083 ), Parkinson’s Disease Foundation , Michael J. Fox Foundation , and the family of Carl and Susan Bolch . Dr Cornejo-Olivas is the recipient of an NIH Fogarty International Clinical Research Fellowship at Vanderbilt University (R24 TW007988).
FundersFunding numbers
family of Carl and Susan Bolch
-
NIH
P50 NS072187, R01 NS065070
NINDS
P50NS062684
VA
1I01BX000531
MJFF
-
Vanderbilt University
R24 TW007988
PDFI
-
FONDECYT
1061083